Strong Momentum Meets Stretched Valuations as CCL Products Reaches All-Time High

2 hours ago
share
Share Via
On 10 June 2026, CCL Products (India) Ltd achieved a significant milestone by reaching its all-time high stock price, reflecting robust performance and sustained growth within the FMCG sector. This landmark event underscores the company’s strong fundamentals and consistent upward trajectory over recent years.
Strong Momentum Meets Stretched Valuations as CCL Products Reaches All-Time High

Session Recap: A Bullish Breakout

The stock demonstrated impressive resilience, touching an intraday high of Rs 1,211.7, outperforming the Tea/Coffee sector's 2.59% gain and the Sensex's modest 0.50% rise. Trading comfortably above all key moving averages—5-day through 200-day—CCL Products has clearly entered a bullish phase, with the trend officially upgrading from mildly bullish on 8 Jun 2026 at Rs 1,170.3. The 1-day delivery volume jumped 18.95% compared to the 5-day average, signalling strong conviction among market participants. Is this breakout sustainable given the technical indicators and volume trends?

Technical Indicators: Mixed Signals Amid Strength

While the overall technical trend is bullish, some indicators present a nuanced picture. Bollinger Bands and Dow Theory confirm upward momentum on both weekly and monthly timeframes, supported by bullish On-Balance Volume (OBV) readings. However, the MACD shows a mildly bearish weekly signal, and the KST indicator is also mildly bearish on the weekly chart, suggesting some short-term consolidation could be ahead. The RSI currently offers no clear signal, indicating the stock is neither overbought nor oversold. Immediate support lies at the 52-week low of Rs 771.85, with resistance levels at the 20-day moving average near Rs 1,090.89 and the 100-day moving average at Rs 1,051.60. The stock’s proximity to its 52-week high at Rs 1,218.10 marks a critical juncture. How might these mixed technical signals influence near-term price action?

Valuation: Premium Multiples Reflect Growth Expectations

Trading at a price-to-earnings (P/E) ratio of 40x, CCL Products commands a premium relative to many FMCG peers. Its price-to-book value stands at 6.54x, and the enterprise value to EBITDA ratio is 22.43x, indicating stretched valuations. The PEG ratio of 1.58x suggests that earnings growth is priced in but not excessively so. The dividend yield remains modest at 0.67%, with a payout ratio of 23.94%, reflecting a balanced approach to shareholder returns and reinvestment. The enterprise value to capital employed ratio of 4.76x aligns with a fair valuation given the company’s return on capital employed (ROCE) of 16.8%. At these valuations, should you be booking profits on CCL Products or can the company grow into this premium?

Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!

  • - New profitability achieved
  • - Growth momentum building
  • - Under-the-radar entry

Get In Before Others →

Financial Trend: Robust Growth and Improving Efficiency

The latest quarterly results ending Mar 2026 highlight a positive financial trajectory. Net sales reached a record ₹1,224.44 crores, with profit after tax (PAT) hitting ₹114.53 crores, the highest quarterly figure to date. Earnings per share (EPS) rose to ₹8.58, reflecting strong bottom-line growth. The operating profit to interest coverage ratio improved to 6.35 times, signalling enhanced ability to service debt. Meanwhile, the debt-to-equity ratio remains conservative at 0.57 times, supporting financial stability. Return on capital employed (ROCE) at 16.07% is the highest recorded, indicating efficient capital utilisation. Does this financial momentum justify the current premium valuations?

Quality Metrics: Solid Fundamentals Backing the Rally

CCL Products is characterised by strong quality indicators. Over the past five years, sales have grown at a compound annual growth rate (CAGR) of 29.18%, with EBIT growth at 18.85%. The company maintains a low net debt-to-equity ratio of 0.47 and no promoter share pledging, which reduces financial risk. Institutional holdings are high at 32.67%, reflecting confidence from sophisticated investors. The average ROE of 16.31% is healthy, although the average ROCE of 14.02% is somewhat modest relative to the recent quarterly spike. Tax ratio and dividend payout remain stable, supporting sustainable earnings retention. How do these quality metrics influence the stock’s risk-reward profile?

Want to dive deeper on CCL Products (India) Ltd? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!

  • - Real-time research report
  • - Complete fundamental analysis
  • - Peer comparison included

Read the Full Verdict →

Long-Term Performance: Outpacing the Market

Over the past decade, CCL Products has delivered a staggering 382.51% return, more than doubling the Sensex’s 178.91% gain. Even in shorter timeframes, the stock has consistently outperformed: 236.33% over five years versus 42.04% for the Sensex, and 91.38% over three years compared to 18.62%. This sustained outperformance is underpinned by steady earnings growth and improving operational metrics. However, the current premium multiples raise questions about the sustainability of this momentum. Should you buy, sell, or hold? With momentum and valuations pulling in opposite directions, no single data point tells the full story — see the complete multi-factor analysis of CCL Products (India) Ltd to find out.

Key Data at a Glance

Current Price: Rs 1,219.55
52-Week High: Rs 1,218.10
1-Year Return: 43.14%
Sensex 1-Year Return: -9.83%
P/E Ratio (TTM): 40x
PEG Ratio: 1.58x
ROCE (Latest): 16.07%
Debt-Equity Ratio: 0.57

Balancing the Bull and Bear Cases

The rally in CCL Products is supported by strong quarterly earnings growth, improving capital efficiency, and robust institutional backing. The stock’s technical profile is largely bullish, with volume trends confirming investor interest. However, valuation multiples are elevated relative to historical averages and sector peers, which may temper upside in the near term. The mixed signals from some technical indicators and the premium price-to-book ratio suggest that caution may be warranted. Investors might consider whether the company’s growth trajectory justifies the current premium or if profit booking is prudent at these levels.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News